{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:24:47Z","timestamp":1761812687598,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.wneu.2018.04.190","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:56:02Z","timestamp":1525438562000},"page":"e17-e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Use of Bone Morphogenetic Protein-2 in Vertebral Column Tumor Surgery: A National Investigation"],"prefix":"10.1016","volume":"117","author":[{"given":"Rafael","family":"De la Garza Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0469-8253","authenticated-orcid":false,"given":"Jonathan","family":"Nakhla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Echt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaroslav","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Altschul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woojin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merritt D.","family":"Kinon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Yassari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.04.190_bib1","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.3171\/2016.8.FOCUS16112","article-title":"Bone graft options for spinal fusion following resection of spinal column tumors: systematic review and meta-analysis","volume":"42","author":"Elder","year":"2017","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2018.04.190_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","article-title":"Bone: formation by autoinduction","volume":"150","author":"Urist","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.wneu.2018.04.190_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J\u00a0Spinal Disord Tech"},{"key":"10.1016\/j.wneu.2018.04.190_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.spinee.2014.12.010","article-title":"Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012","volume":"15","author":"Martin","year":"2015","journal-title":"Spine J"},{"key":"10.1016\/j.wneu.2018.04.190_bib5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/BRS.0000000000001126","article-title":"Association Between BMP-2 and Carcinogenicity","volume":"40","author":"Skovrlj","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5 suppl 2","key":"10.1016\/j.wneu.2018.04.190_bib6","first-page":"ONS423","article-title":"A\u00a0comprehensive review of the safety profile of bone morphogenetic protein in spine surgery.","volume":"62","author":"Benglis","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.190_bib7","first-page":"549","article-title":"The controversy surrounding bone morphogenetic proteins in the spine: a review of current research","volume":"87","author":"Hustedt","year":"2014","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.wneu.2018.04.190_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.spinee.2017.04.030","article-title":"Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?","volume":"17","author":"Guzman","year":"2017","journal-title":"Spine J"},{"key":"10.1016\/j.wneu.2018.04.190_bib9","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/neuros\/nyw084","article-title":"Spine oncology-metastatic spine tumors","volume":"80","author":"Choi","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.190_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10585-013-9608-3","article-title":"Prolonged survival following aggressive treatment for metastatic breast cancer in the spine","volume":"31","author":"Zadnik","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.wneu.2018.04.190_bib11","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2016.5.FOCUS16118","article-title":"Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection","volume":"41","author":"Sciubba","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2018.04.190_bib12","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/neuros\/nyw064","article-title":"Spine oncology - primary spine tumors","volume":"80","author":"Dea","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.190_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A\u00a0critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.wneu.2018.04.190_bib14","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1007\/s00586-015-3870-9","article-title":"Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2)","volume":"25","author":"Vavken","year":"2016","journal-title":"Eur Spine J"},{"key":"10.1016\/j.wneu.2018.04.190_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3171\/2014.10.SPINE14338","article-title":"A\u00a0comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis","volume":"23","author":"Cahill","year":"2015","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2018.04.190_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jocn.2017.05.007","article-title":"Bone morphogenetic protein (BMP-2) usage and cancer correlation: an analysis of 10,416 spine fusion patients from a multi-center spine registry","volume":"43","author":"Bains","year":"2017","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2018.04.190_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/BRS.0000000000001671","article-title":"The risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion","volume":"41","author":"Dettori","year":"2016","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2018.04.190_bib18","first-page":"401737","article-title":"Bone morphogenetic proteins in spinal surgery: what is the fusion rate and do they cause cancer?","author":"Malham","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2018.04.190_bib19","first-page":"951537","article-title":"Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis","author":"Carragee","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018309100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018309100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:22:29Z","timestamp":1761812549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018309100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":19,"alternative-id":["S1878875018309100"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.04.190","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Bone Morphogenetic Protein-2 in Vertebral Column Tumor Surgery: A National Investigation","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.04.190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}